Microorganisms have been developed well to produce enzymes. The representative microbes are bacteria, yeast, fungus and microalgae. The discovery of enzymes as biocatalysts has led to various biotechnological developments. The capability of enzymes to catalyse various chemical reactions both in vivo and in vitro has led them to applications in various industries, such as food, feed, pharmaceutical, diagnostics, detergent, textile, paper, leather, and fine chemical industries. Efforts are directed both to the advancement of cell factories and enzymes as well as of design of new processes, concepts and technologies for fermentation process.
https://microbiosci.creative-biogene.com/fermentation-for-enzymes.html
Creative Biogene can provide a variety of protein purification technical services, including lab-scale protein purification, large-scale protein purification, fusion tag protein purification, and tag-free protein purification. Protein purification resins and prepacked columns are also available. Protein purification at the lab scale bridges the gap between small-scale exploratory protein purification and high-throughput operations, such as industrial-scale manufacturing. Each stage of protein purification presents different challenges during scale-up, a result of prolonged fermentation times and higher cell densities in large-scale cell cultures.
https://microbiosci.creative-biogene.com/protein-purification-at-different-…
Creative Bioarray offers FISH services for a variety of specimen types, including non-paraffin, paraffin and paraffin tissue microarrays. Our FISH services can be performed to enumerate the copy number of cancer-related genes and patterns of gene-related gains and losses; map the location of DNA sequences, genes or transgene insertions; and determine the presence or absence of interspecies cells in xenograft or chimeric animal models. With our FISH services, Creative Bioarray will provide you with a written report that includes a brief description of the methods used, a brief description of the results, and final conclusion of the tests.
https://www.histobiolab.com/fluorescence-in-situ-hybridization.html
Immunohistochemistry (IHC), which utilizes monoclonal and polyclonal antibodies to detect specific antigens in situ, is a very powerful tool for imaging discrete components in tissues.
The science of IHC is evolving, as evidenced by the development of increasingly sophisticated automated staining platforms, production of specific antibodies against a wide range of species, and the availability of a range of novel biomarkers.
https://www.histobiolab.com/immunohistochemistry-services.html
Creative Bioarray offers state-of-the-art molecular pathology services on multiple high-throughput test platforms, including DNA, RNA and protein preparation from a large number of samples for molecular assays, massive parallel sequencing, Sanger sequencing, gene expression analysis and quantitative PCR.
https://www.histobiolab.com/molecular-pathology-services.html
Creative Bioarray offers state-of-the-art <a href="https://www.histobiolab.com/molecular-pathology-services.html">molecular pathology services</a> on multiple high-throughput test platforms, including DNA, RNA and protein preparation from a large number of samples for molecular assays, massive parallel sequencing, Sanger sequencing, gene expression analysis and quantitative PCR.
Creative Bioarray offers state-of-the-art <a href="https://www.histobiolab.com/molecular-pathology-services.html">molecular pathology services</s> on multiple high-throughput test platforms, including DNA, RNA and protein preparation from a large number of samples for molecular assays, massive parallel sequencing, Sanger sequencing, gene expression analysis and quantitative PCR.
<a href="https://www.histobiolab.com/immunohistochemistry-services.html">Immunohistochemistry</a> (IHC), which utilizes monoclonal and polyclonal antibodies to detect specific antigens in situ, is a very powerful tool for imaging discrete components in tissues.
The science of IHC is evolving, as evidenced by the development of increasingly sophisticated automated staining platforms, production of specific antibodies against a wide range of species, and the availability of a range of novel biomarkers.
Hello all,
Hope you all are doing well.
This email is a reminder that we are hosting this month's Open Community
Call tomorrow (*27 April 2025*, Sunday*)* from 6:00 pm to 7:00 pm IST with
a keen focus on discussing certain Global Trends
<https://meta.wikimedia.org/wiki/Wikimedia_Foundation_Annual_Plan/2025-2026/…>
which have been tracked by WMF and will serve as a central focus of the
different aspects of the WMF Annual Plan for 2025-2026.
While we are discussing multiple trends; during the SAOCC we are hosting a
45 min session including breakouts in which we will discuss the following
trends in detail.
1.
Contributors: People participate eagerly in online spaces that provide
rewarding connections.
2.
Neutrality: Struggles over neutral and verifiable information threaten
access to knowledge projects and their contributors.
3.
Content and AI: Digital information that is created and verified by
humans is the most valuable asset in the AI tech platform wars.
Please add the following to your respective calendars and we look forward
to seeing you on the call.
[SAOCC] Open Community Call
Date: 27 April 2025
Time: 1800-1900 [6 pm to 7 pm] (IST)
Google Link: https://meet.google.com/ffs-izis-bow
Etherpad link: https://etherpad.wikimedia.org/p/South_Asia_Community_Call
Metapage: https://meta.wikimedia.org/wiki/South_Asia_Open_Community_Call
Look forward to connecting with you all,
Thank you!
Warm regards,
Nitesh & Nivas